FDA Inspection 1241494 — Professor Meletios A. Dimopoulos, MD

Professor Meletios A. Dimopoulos, MD — FEI 3011051624

The FDA completed an inspection of Professor Meletios A. Dimopoulos, MD on May 24, 2024 in Athens. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 24, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Athens (Greece)

Additional Details

Clinical Investigator (CI)